First patient receives AI-designed CAR T cell therapy for ovarian cancer
Roswell Park and Generate Biomedicines have started a clinical trial of GB-5267, an AI-built CAR T cell therapy for ovarian cancer. The treatment aims to avoid chemotherapy and its harsh side effects.